Rafferty Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $142K | Sell |
|
|||||
|
2025
Q2 | $121K | Buy |
|
|||||
|
2025
Q1 | $82.4K | Sell |
|
|||||
|
2024
Q4 | $60.1K | Sell |
|
|||||
|
2024
Q3 | $54.5K | Sell |
|
|||||
|
2024
Q2 | $44K | Sell |
|
|||||
|
2024
Q1 | $46.9K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $54K | Buy |
|
|||||
|
2022
Q1 | $80K | Sell |
|
|||||
|
2021
Q4 | $127K | Buy |
|
|||||
|
2021
Q3 | $71K | Buy |
|